NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$76.00
-2.01 (-2.58%)
Close of Nov 06, 2026 · end-of-day data
RDNT 8-K filings in 2024
Every material Form 8-K RadNet filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
RadNet and its subsidiary RadNet Management entered into an amendment to their credit agreement that lowers interest rates on the term loans and revolving credit facility by 0.25%. The company borrowed $872,812,500 in new term loans to refinance existing term loans, and it estimates the change will reduce annual cash interest expense by about $2.2 million.
New term loans of $872,812,500 refinance existing term loans under the Restated Credit Agreement dated April 18, 2024.
Term loan rate reduced to Term SOFR plus 2.25% or alternate base rate plus 1.25%; revolver initially Term SOFR plus 2.75% or alternate base rate plus 1.75%.
RadNet estimates about $2.2 million in annual cash interest expense reduction; the company provided six months of call protection to lenders.
Maturity dates, covenants and security are unchanged; the closing was expected the following week per the November 22, 2024 press release.
RadNet reported third quarter 2024 revenue of $461.1 million, up 14.7%, and Adjusted EBITDA of $73.7 million, up 27.2%, with Adjusted diluted EPS of $0.18 versus $0.13. GAAP net income attributable to common stockholders fell to $3.2 million ($0.04 per diluted share) from $17.5 million ($0.25), and the company raised its Imaging Center revenue and Adjusted EBITDA guidance for 2024.
Q3 2024 Total Company Revenue was $461.1 million, up from $402.0 million; Adjusted EBITDA was $73.7 million, up from $57.9 million.
GAAP net income attributable to RadNet common stockholders was $3.2 million, or $0.04 per diluted share, versus $17.5 million, or $0.25, in Q3 2023; the company cited an $8.1 million non-cash loss from interest rate swaps among one-time ite
Adjusted diluted EPS was $0.18 versus $0.13 a year earlier.
Imaging Center 2024 guidance now projects Total Net Revenue of $1,710 - $1,760 million (up from $1,685 - $1,735 million) and Adjusted EBITDA of $262 - $270 million (up from $257 - $267 million).
RadNet appointed Cornelis "Kees" Wesdorp, former Hellman & Friedman managing director and ex-Philips executive, as President and Chief Executive Officer of its Digital Health segment, effective October 1, 2024. The filing sets his pay package, including a signing bonus of $750,000 in stock and restricted stock units for 50,000 shares, which signals the company's investment in its eRad and artificial intelligence businesses.
Wesdorp's annual base salary is €636,000, with bonuses equal to his annual compensation in 2026 and 2027.
Signing bonus of $750,000, payable in RadNet common stock valued at the start of employment.
Restricted stock units for 50,000 shares vest in 10,000-share increments over five anniversaries of his start date.
RadNet reported second-quarter 2024 revenue of $459.7 million, up 13.9%, and raised its 2024 guidance for Imaging Center revenue, Adjusted EBITDA and free cash flow. GAAP results were weaker: the company posted a net loss attributable to RadNet of $3.0 million, or $(0.04) per share, compared with net income of $8.4 million, or $0.12 per diluted share, a year earlier.
Total Company Revenue rose 13.9% to $459.7 million in Q2 2024 from $403.7 million in Q2 2023; Adjusted EBITDA rose 19.7% to $72.3 million.
GAAP net loss attributable to RadNet was $3.0 million in Q2 2024, versus net income of $8.4 million in Q2 2023; Adjusted Diluted EPS was $0.16 versus $0.10.
Imaging Center revised 2024 Total Net Revenue guidance to $1,685-$1,735 million and Adjusted EBITDA guidance to $257-$267 million, both raised from the post-Q1 ranges.
Cash balance was $741.7 million at June 30, 2024, after an April 2024 refinancing that funded about $168 million of additional cash.
RadNet reported first quarter 2024 revenue of $431.7 million, up 10.5% from a year earlier, and Adjusted EBITDA of $58.5 million, up 21.4%. The company raised its 2024 guidance ranges for revenue, Adjusted EBITDA and free cash flow, while still reporting a net loss attributable to common stockholders of $2.8 million for the quarter.
Total company revenue rose 10.5% to $431.7 million; Adjusted EBITDA rose 21.4% to $58.5 million for the quarter ended March 31, 2024.
GAAP net loss attributable to RadNet common stockholders was $2.8 million, or $(0.04) per share, versus a $21.0 million loss, or $(0.36) per share, a year earlier.
Imaging Center segment revenue guidance for 2024 was revised to $1,675 - $1,725 million from $1,650 - $1,700 million.
Cash and cash equivalents were $527.0 million at March 31, 2024, after a March common stock offering that raised net proceeds of approximately $219 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every RadNet filing is on SEC EDGAR ↗. 8-K briefs of other companies →